The effect of stopping phenprocoumon 5 days preoperatively: A retrospective study

BACKGROUND: Clinicians lack substantiated guidance on when vitamin K antagonist (VKA) treatment should be interrupted preoperatively, especially with regard to phenprocoumon, with its long half‐life of 5.5 days. OBJECTIVE: To evaluate the efficacy of discontinuing phenprocoumon 5 days preoperatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Knol, Silke, Mallo, Mascha, Tromp Meesters, Reinier, Westerink, Jan, van de Ree, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332713/
https://www.ncbi.nlm.nih.gov/pubmed/30656280
http://dx.doi.org/10.1002/rth2.12159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332713/
https://www.ncbi.nlm.nih.gov/pubmed/30656280
http://dx.doi.org/10.1002/rth2.12159

Ejemplares similares